Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Published loading...Updated

Xencor (NASDAQ:XNCR) Now Covered by William Blair

William Blair started coverage on shares of Xencor (NASDAQ:XNCR – Free Report) in a research report sent to investors on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating on the biopharmaceutical company’s stock. William Blair also issued estimates for Xencor’s Q1 2025 earnings at ($0.84) EPS, Q2 2025 earnings at ($0.82) EPS, Q3 […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

themarketsdaily.com broke the news in on Thursday, April 24, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal